Jan 01, 2022
RIA helped a sponsor to design a new Phase 3 Clinical study with "Clinical Relapse" as outcome measures for the treatment of Multiple Sclerosis
Challenge
Identify all Phase 3, completed studies with "relapse" as an outcome measure.
Collate key design elements (i.e. protocolsynopsis) for all studies of interest
Outcomes
Phase 3, completed studies with "relapse" as an outcome measure for MS treatment were quickly identified.
Enabled protocol design based on precedents.
Why Vivpro?
RIA saves time and delivers intelligence at high quality EQUALS TO more time for strategy.
Vivpro RIA | Competition | Manual |
|---|---|---|
Time Efficient: Result in 15 mins | Less Time Efficient: Result in 1 day | Time Inefficient: Result in 3 days |
Top Quality Result: Human & Machine Assisted | Normal Quality: ResultMachine Assisted | Ok Quality Result: Human Assisted |
